The risk-based breast screening (RIBBS) study protocol: a personalized screening model for young women

Author:

Gennaro Gisella,Bucchi LauroORCID,Ravaioli Alessandra,Zorzi Manuel,Falcini Fabio,Russo Francesca,Caumo FrancescaORCID

Abstract

AbstractThe optimal mammography screening strategy for women aged 45–49 years is a matter of debate. We present the RIBBS study protocol, a quasi-experimental, prospective, population-based study comparing a risk- and breast density-stratified screening model (interventional cohort) with annual digital mammography (DM) screening (observational control cohort) in a real-world setting. The interventional cohort consists of 10,269 women aged 45 years enrolled between 2020 and 2021 from two provinces of the Veneto Region (northen Italy). At baseline, participants underwent two-view digital breast tomosynthesis (DBT) and completed the Tyrer-Cuzick risk prediction model. Volumetric breast density (VBD) was calculated from DBT and the lifetime risk (LTR) was estimated by including VBD among the risk factors. Based on VBD and LTR, women were classified into five subgroups with specific screening protocols for subsequent screening rounds: (1) LTR ≤ 17% and nondense breast: biennial DBT; (2) LTR ≤ 17% and dense breast: biennial DBT and ultrasound; (3) LTR 17–30% or LTR > 30% without family history of BC, and nondense breast: annual DBT; (4) LTR 17–30% or > 30% without family history of BC, and dense breast: annual DBT and ultrasound; and (5) LTR > 30% and family history of BC: annual DBT and breast MRI. The interventional cohort is still ongoing. An observational, nonequivalent control cohort of 43,000 women aged 45 years participating in an annual DM screening programme was recruited in three provinces of the neighbouring Emilia-Romagna Region. Cumulative incidence rates of advanced BC at three, five, and ten years between the two cohorts will be compared, adjusting for the incidence difference at baseline.Trial registration This study is registered on Clinicaltrials.gov (NCT05675085).

Funder

Regione del Veneto

Publisher

Springer Science and Business Media LLC

Reference52 articles.

1. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (2008) European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition Summary document Ann Oncol 19:614–622

2. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F et al (2015) Breast-cancer screening: viewpoint of the IARC Working Group. N Engl J Med 372:2353–2358

3. Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L et al (2012) Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen 19(Suppl 1):72–82

4. European Commission Initiative on Breast and Colorectal cancer. https://healthcare-quality.jrc.ec.europa.eu. Accessed 15 Mar 2023.

5. Kerlikowske K, O’Kane ME, Esserman LJ (2014) Fifty years of age-based screening: time for a new risk-based screening approach. Evid Based Med 19:183

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3